PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1876144
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1876144
The Global Synthetic Absorbable Sutures Market is witnessing steady growth driven by a significant rise in surgical procedures worldwide and continuous advancements in suture technology. According to Fortune Business Insights, the market was valued at USD 2.68 billion in 2024, is projected to grow to USD 2.83 billion in 2025, and is expected to reach USD 4.94 billion by 2032, expanding at a CAGR of 8.3% during the forecast period (2025-2032).
Synthetic absorbable sutures, made from materials such as Polyglactin 910, Poliglecaprone 25, and Polydioxanone, are widely used for wound closure in both elective and emergency surgeries. These sutures naturally degrade in the body over time, eliminating the need for removal and minimizing post-operative complications. The increasing preference for absorbable sutures in surgical applications such as gynecology, orthopedics, and cardiology is boosting global demand. North America dominated the market in 2024, holding a 42.91% share due to advanced healthcare infrastructure and high surgical volumes.
Market Dynamics
Market Drivers - Rising Global Surgical Procedures Enhance Demand
The market growth is primarily driven by the surge in surgical interventions worldwide. Advancements in medical infrastructure, coupled with an aging population, have increased the prevalence of surgeries such as cesarean sections, orthopedic replacements, and cardiovascular procedures. For example, according to the World Health Organization (WHO), approximately 21% of childbirths worldwide were performed via C-section in 2020, with the rate expected to rise to 29% by 2030.
Similarly, the Mass General Brigham reported that over 900,000 cardiac surgeries are performed annually in the U.S., while the Canadian Institute for Health Information (CIHI) recorded 117,000 hip and knee replacements in 2021-2022, representing a 5.9% increase from the previous year. These trends underscore the growing dependence on high-quality absorbable sutures for improved wound management and recovery outcomes.
Market Restraints - Shift Toward Advanced Wound Closure Alternatives
Despite strong demand, market expansion is restrained by the increasing adoption of alternative wound closure technologies such as surgical staplers, hemostats, and tissue adhesives. These alternatives provide faster application, reduced scarring, and minimal tissue trauma. According to Suture Planet (February 2025), staplers offer quicker closure with reduced infection risks compared to traditional sutures, making them preferable in emergency and trauma cases. The growing reliance on these advanced options is gradually impacting the usage rate of synthetic sutures in specific medical procedures.
Market Opportunities - Expanding Healthcare Infrastructure in Emerging Markets
Rapid healthcare development in emerging economies presents lucrative opportunities for market growth. Rising hospital construction, improved access to surgical care, and increased government healthcare spending are driving the adoption of absorbable sutures. In June 2025, Inamdar Multispecialty Hospital (India) and Hospitales MAC (Mexico) both inaugurated new facilities offering advanced surgical services. As hospitals modernize across Asia, Africa, and Latin America, the rising number of surgical procedures is expected to substantially increase demand for synthetic absorbable sutures.
Market Challenges - Post-Surgical Complications and Inflammation Risks
While synthetic absorbable sutures are known for their predictable absorption rate, complications such as inflammatory reactions, wound dehiscence, or infection occasionally occur. These risks, influenced by patient sensitivity or improper surgical technique, may limit adoption among healthcare providers seeking zero-complication closures. Continuous material innovation and antimicrobial coating developments are key to overcoming these challenges.
Market Trends
Technological Innovation and Product Launches Accelerate Market Growth
Recent advancements in antimicrobial-coated and bioengineered sutures are reshaping the synthetic absorbable sutures landscape. For example, in September 2023, Genesis MedTech received approval from China's National Medical Products Administration (NMPA) to launch antibacterial resorbable sutures, improving infection resistance. Moreover, the rise of knotless absorbable sutures in minimally invasive and laparoscopic surgeries is enhancing precision and reducing tissue trauma. Such developments highlight the market's shift toward efficiency, safety, and patient comfort.
By Product:
The multifilament (braided) sutures segment dominated in 2024, owing to their superior knot security, flexibility, and tensile strength. These sutures are widely used in cardiovascular and orthopedic surgeries. The monofilament sutures segment is also growing due to their application in vascular procedures where smooth tissue passage reduces infection risk.
By Material:
Polyglactin 910 led the market in 2024 and will maintain dominance through 2032, driven by continuous product launches using this material. For example, Healthium Medtech Limited launched TRUMAS(TM) in August 2023, a synthetic absorbable suture designed for minimal access surgeries. Poliglecaprone 25 and Polydioxanone segments are expected to record stable growth due to their use in delicate tissue surgeries.
By Application:
The orthopedic segment held the largest share in 2024, supported by increasing joint replacement procedures and trauma surgeries. The gynecology segment follows, driven by the global rise in cesarean deliveries-33.4% of births in Canada in 2023, according to CIHI. Cardiology and general surgery segments are also witnessing steady growth, fueled by expanding use of absorbable sutures in minimally invasive operations.
By End-user:
Hospitals and Ambulatory Surgical Centers (ASCs) dominated the market in 2024 due to high patient admission rates and well-equipped surgical infrastructure. According to the Australian Institute of Health and Welfare (AIHW), hospital surgical admissions rose from 735,460 in 2022-2023 to 778,466 in 2023-2024, indicating sustained demand for wound closure materials.
North America led the market with a value of USD 1.15 billion in 2024, capturing 42.9% of the global share. Factors such as advanced healthcare systems, frequent surgical procedures, and participation of companies in medical conferences-like Dolphin Sutures at FIME 2025 in Miami-enhance visibility and growth.
Europe ranked as the third-largest region, driven by rising cardiac and orthopedic surgeries. The National Adult Cardiac Surgery Audit (U.K.) reported 24,807 cardiac operations between 2021 and 2022.
Asia Pacific is projected to record the highest CAGR through 2032, supported by expanding medical tourism, rising surgical volumes, and the presence of leading manufacturers such as Lotus Surgicals, Healthium Medtech, and ORION Sutures.
Latin America and the Middle East & Africa are showing moderate growth, driven by increasing chronic disease treatment and hospital expansions.
Competitive Landscape
The market features strong competition among global leaders including Johnson & Johnson Services, Inc., DemeTECH Corporation, Medtronic, B. Braun SE, and Healthium Medtech Limited. Key strategies include new product launches, acquisitions, and medical event participation.
Conclusion
The Global Synthetic Absorbable Sutures Market is set to expand from USD 2.68 billion in 2024 to USD 4.94 billion by 2032, supported by increasing surgical procedures, material innovation, and the expansion of healthcare facilities worldwide. With the rapid rise in minimally invasive and orthopedic surgeries, coupled with growing medical infrastructure across emerging economies, synthetic absorbable sutures are expected to remain a cornerstone of modern surgical wound management through the next decade.
Segmentation By Product
By Material
By Application
By End-user
By Region